Updated: Multiple Biosimilars To Avastin Have Launched In EU
Industry Had Expected June Roll-Out
Executive Summary
Roche’s biggest seller, Avastin, has fallen to biosimilar competition in Europe, with at least one company confirming launch to Generics Bulletin.